Мykola Ostrovskyy

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

William W. Busse, Eugene R. Bleecker, J Mark FitzGerald et al. · The Lancet Respiratory Medicine · 2018 · 311 citations

Pharmacy, Pharmacology, Pharmacotherapy +6

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling et al. · The Lancet Respiratory Medicine · 2023 · 141 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial

Mario Castro, Alberto Papi, Celeste Porsbjerg et al. · The Lancet Respiratory Medicine · 2025 · 67 citations · Full text

Medicine, Clinical Sciences, Pharmacology +16

3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats

Holly Sue Hake, Jazmyne K.P. Davis, River R. Wood et al. · Physiology & Behavior · 2018 · 63 citations · Full text

Life Sciences, Neuroscience, Pharmacology +12

Activation of Nigrostriatal Dopamine Neurons during Fear Extinction Prevents the Renewal of Fear

Courtney A. Bouchet, Megan A Miner, Esteban C. Loetz et al. · Neuropsychopharmacology · 2017 · 60 citations

Life Sciences, Neurobiology, Neuroscience +14